Overview

* InMode Q3 2025 revenue of $93.2 mln beats analyst expectations

* Net income for Q3 2025 misses analyst estimates

Outlook

* InMode ( INMD ) maintains full-year 2025 revenue guidance between $365 mln and $375 mln

* Non-GAAP EPS for 2025 expected between $1.55 and $1.59

* Company continues to monitor geopolitical developments in Israel

Result Drivers

* REVENUE DECLINE - Q3 revenue decreased due to absence of pre-order sales from previous year

* CONSUMABLES GROWTH - Revenue from consumables and services increased by 26% year-over-year

* U.S. SALES IMPACT - Lower U.S. sales affected operating margins, the company's most profitable region

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $93.17 $88.34

Revenue mln mln (7

Analysts

)

Q3 Net Miss $21.86 $22.67

Income mln mln (5

Analysts

)

Q3 Gross 78%

Margin

Q3 Beat $25.61 $24.98

Pretax mln mln (6

Profit Analysts

)

Q3 $51.41

Operatin mln

g

Expenses

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

* Wall Street's median 12-month price target for Inmode Ltd ( INMD ) is $16.00, about 8.6% above its November 4 closing price of $14.63

* The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)